PATENT CLAIM ANALYSIS

Application Number: 16314748
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["549", "264000"]

Abstract:
The present invention relates to the field of pharmaceuticals, especially to the field of veterinary drugs, and more particularly to a crystal form of milbemycin A3 oxime, able to be characterized by the X-ray powder diffraction spectrogram, infrared absorption (IR) spectrogram, differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA), etc. Furthermore, the present invention also relates to a method for preparing the crystal form of milbemycin A3 oxime and to a use of the crystal form of milbemycin A3 oxime as an insecticidal and acaricidal agent.

Claim (Index 5):
The method according to  claim 3 , wherein the concentration of the Milbemycin A3 oxime in the solvent is 100 g/L to 500 g/L, preferably 200 g/L to 400 g/L.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 1.85455
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15239819', '15562155', '15562187', '13001715', '14254747']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6801360865909875
- 35 USC 102 Novelty (BERT): 0.5073396281367022
- Combined Prediction Score: 0.6628564407455589
- Mean Citation Score: 189.245144
- Max Citation Score: 226.12782
- Similarity Product: 154.4653226502943

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test